RxDoctor Payments DataLook up a doctor →

Allan Coates, DO

Gastroenterology · Wyoming, MINPI 1972510378

Payments from drug & device makers

$5,850,421in general payments, 2019–2025

Across 2,562 payments — averaging $2283.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$1.4M
  • Intercept Pharmaceuticals, Inc.$983K
  • AbbVie$830K
  • Bristol Myers Squibb$418K
  • Eli Lilly$336K
  • Teva Pharmaceuticals USA, Inc.$311K
  • plus $1.6M from 37 others
$158,221in research payments, 2019–2025

Across 13 payments — averaging $12,171 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Celltrion, Inc.$138K
  • Eli Lilly$20K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,850,421 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan

Medicare billing

Part B allowed, 2024
$334,774
Medicare patients
689
Services billed
5,795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Wyoming

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →